DJIA 17,855.70 -72.50 -0.40%
NASDAQ 4,922.67 -16.65 -0.34%
S&P 500 2,084.18 -5.28 -0.25%
market minute promo

Pfizer (NYSE: PFE)

33.56 -0.28 (-0.83%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

PFE $33.56 -0.84%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $33.75
Previous Close $33.84
Daily Range $33.34 - $33.90
52-Week Range $27.51 - $35.53
Market Cap $205.7B
P/E Ratio 24.20
Dividend (Yield) $1.12 (3.3%)
Ex-Dividend Date
Dividend Pay Date
Volume 9,497,802
Average Daily Volume 26,198,704
Current FY EPS $2.05




Drug Makers

Pfizer (PFE) Description

A research-based pharmaceutical company, Pfizer discovers, develops, manufactures, and markets prescription medicines such as Lipitor, Celebrex, and Viagra. Website:

News & Commentary

2 Under-the-Radar Updates Pfizer Inc.'s Shareholders Need to Know About

Pfizer's size has become a problem for the investing community. During its recent first-quarter conference call, for example, the pharma giant barely had enough time to update investors on two key experimental drugs, and made no mention of numerous others. Here's a deeper look at just two under-the-radar clinical updates that shareholders need to know about right now.

iShares Core High Dividend ETF Experiences Big Inflow

Dow Jones (DJIA) Today: E I Du Pont De Nemours & Company (DD) Leads The Day Higher, Pfizer (PFE) Lag

Dow Jones (DJIA) Today: E I Du Pont De Nemours & Company (DD) Leads The Day Higher, Pfizer (PFE) Lags

Is There A Silver Lining For Pfizer Amid Challenging Conditions?

Pfizer, Inc. (PFE) Ex-Dividend Date Scheduled for May 06, 2015

Warren Buffett's Portfolio: Pharmaceutical Companies the Oracle of Omaha Should Love

Healthcare may not be a big ingredient in Warren Buffett's portfolio, but the Oracle of Omaha would be wise to consider these three pharmaceutical companies as potential investments.

Will Zoetis (ZTS) Earnings Disappoint Expectation in Q1? - Analyst Blog

Merck Seems Confident About New Launches

3 Stocks Improving Performance Of The Health Care Sector

pSivida, Moore's Law, Pfizer, And The Next Regeneron

See More PFE News...

PFE's Top Competitors

PFE $33.56 (-0.83%)
Current stock: PFE
JNJ $98.91 (-0.59%)
Current stock: JNJ
ROG $71.03 (-0.73%)
Current stock: ROG
GSK $46.12 (1.14%)
Current stock: GSK